You are here:

Governance structure

a diagram showing the NBA Governance structure

FIGURE 3.1 NBA Governance structure

Governance Committees

An overview of the NBA Governance structure is shown in Figure 3.1.

Five governance committees assist the NBA General Manager to plan and manage corporate governance, outcome delivery, strategic projects and stakeholder interests:

  • The Senior Executive Managers' Committee is the NBA's primary policy and process decision-making body and comprises the senior executive management team. The committee meets once a week and supports the General Manager in operational matters relating to outcome delivery, risk management, stakeholder management, ethics and governance of the NBA.
  • The Management Committee is a wider group of managers that meets once a month to discuss and progress operational and performance issues.
  • The ICT Steering Committee, chaired by the NBA General Manager, provides strategic direction and oversight of the NBA's information, communications, technology and knowledge management activities. Membership of the committee includes Senior Executive Management, the Chief Finance Officer and the Deputy Chief Information Officer.
  • The Project Governance Boards, chaired by the NBA General Manager, provide governance oversight of major strategic projects of material significance. The terms of reference and membership of each board is specific to the project. Project Governance Boards operated in 2015-16 for the following projects:
    • BloodNet/ABDR Development and Enhancement
    • Ig Governance Project
    • BloodStar
    • Pilot to update PBM Guidelines: Module 1
    • National Blood Sector Research and Development Pilot.
  • The Audit Committee provides independent assurance and advice to the General Manager on strategies to enhance the organisation's governance control and risk management framework, the planning and conduct of the NBA internal audit program and support financial and legislative compliance. The Committee met six times in 2015-16. Its membership in 2015-16 was as follows:
    • Mr Ken Barker (Chair)
    • Mr Andrew Harvey
    • Mr Paul Bedbrook
    • Representatives from the ANAO and the NBA internal auditors (KPMG) also attend meetings as observers for most matters.

NBA Management

As at June 30, 2016 the NBA Senior Executive Management team comprised the following:

  • Acting General Manager – Mr Michael Stone
  • Executive Director Fresh Blood, Data & Clinical Development - Ms Sandra Cochrane
  • Executive Director Enabling Services Group and Chief Information Officer - Mr Peter O'Halloran
  • Executive Director Supply Management Plasma & Recombinant Products – Mr Ian Kemp

As at 30 June 2016, the NBA comprised the following 15 teams/business streams:

  • Blood Operations Centre
  • Blood Sector Clinical Development
  • Corporate and Information Management
  • Data and Information Analysis
  • Finance and Risk Management
  • Health Provider Engagement
  • Horizon Scanning
  • Human Resources
  • Immunoglobulin Governance
  • Information Services
  • Legal Services
  • Research and Evidence Assessment
  • Secretariat and Communications
  • Supply Management - Plasma & Recombinant Products
  • Supply Management – Fresh Blood

Internal Audit

The NBA's internal audit program, guided by the Audit Committee, plays a key part in risk mitigation. The NBA has a comprehensive risk management framework that includes a living risk register and an annual bottom-up hierarchical risk review process. The Audit Committee reviews the risk register on an annual basis as a key input in developing the internal audit program.

KPMG conducted a range of audits and reviews in line with the work program developed in conjunction with the Audit Committee. The 2015-16 work program encompassed reviews of: Business Continuity Plan; internal controls; leave; procurement under $80,000 and travel.

The Audit Committee continued to monitor the implementation of internal audit report recommendations through status reports.